Table 2. Multiple comparisons of circulating adipokines among different phenotypes of body size.
| Adipokines | Participants | ||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Total (n = 350) | NWMH (n = 53) | NWMUH (n = 21) | OWMH (n = 37) | OWMUH (n = 71) | MHO (n = 37) | MUHO (n = 131) | |
| Omentin-1 (ng/mL) | 336.5 ± 148.7 | 250.9 ± 169.3a,b | 270.9 ± 230.9c | 282.2 ± 127.5d,e | 415.7 ± 123.7c,e,f,b | 294.4 ± 151.4f | 362 ± 121.7d,a |
| Vaspin (µg/L) | 1.01 ± 1.42 | 0.98 ± 1.46 | 1.45 ± 2.23 | 0.61 ± 0.52 | 1.01 ± 1.80 | 0.81 ± 0.91 | 1.11 ± 1.35 |
| RBP-4 (µg/mL) | 58.97 ± 5.77 | 65.99 ± 0.66 | 68.93 ± 0.76 | 55.23 ± 14.17 | 59.95 ± 3.57 | 58.75 ± 2.84 | 59.20 ± 2.33 |
NWMH: normal-weight metabolically healthy; NWMUH: normal-weight metabolically unhealthy; OWMH: overweight metabolically healthy; OWMUH: overweight metabolically unhealthy; MHO: metabolically healthy obesity; MUHO: metabolically unhealthy obesity; BMI: body mass index; RBP-4: retinol binding protein-4. Data are presented as mean ± SD; corresponding letters are representatives of corresponding significant differences of serum adipokines among different phenotypes of body size (P < 0.05 is significant).